NASDAQ$NUWE
Nuwellis Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Nuwellis reported a revenue increase driven by consumables utilization and gross margin gains due to manufacturing efficiencies.
Nuwellis, Inc. reported a 6% increase in revenue to $2.2 million for the second quarter of 2024, driven by a 30% increase in heart failure and critical care consumables utilization. The company's gross margin improved to 67.2%, and operating expenses decreased by 38%. However, the company reported a net loss of $7.7 million, or $18.85 per share.
- Revenue increased by 6% to $2.2 million compared to the second quarter of 2023.
- Critical Care revenue experienced a 28% growth compared to the prior year quarter, with Heart Failure consumables utilization growing by 35%.
- Gross margin improved to 67.2% compared to 55.3% in the prior-year quarter.
- Total operating costs were reduced by 38% compared to the prior-year quarter.
Headline financials
Revenue & EPS history
Nuwellis · Revenue · Quarterly
$2.19M
Forward guidance
The release contains forward-looking statements regarding new market opportunities and anticipated growth in 2024 and beyond. These statements are subject to risks and uncertainties.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2024
-5.5%
Avg return
Earnings day
-10.5%
Avg return
5 days after
-18.5%
Avg return
30 days after
28%
15 / 54 earnings
Positive
+51.9%
Q1 2024
Best reaction
-29.9%
Q1 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | -5.0% | -86.3% | |
| Q4 2025 | +2.4% | -2.3% | -16.3% | |
| Q3 2025 | -3.4% | -11.9% | -18.0% | |
| Q2 2025 | +0.4% | +8.4% | -24.0% | |
| Q1 2025 | -3.1% | -5.1% | -68.7% | |
| Q4 2024 | -4.0% | -7.9% | -25.4% | |
| Q3 2024 | +6.6% | -0.6% | -28.2% | |
| Q2 2024 | -14.3% | -30.2% | -46.4% | |
| Q1 2024 | +51.9% | +47.1% | +29.4% | |
| Q4 2023 | -20.7% | -18.3% | -36.7% | |
| Q3 2023 | -10.0% | -12.9% | -14.3% | |
| Q2 2023 | -5.1% | -3.0% | -22.2% | |
| Q1 2023 | -29.9% | -37.8% | -34.6% | |
| Q4 2022 | -5.1% | -6.5% | -41.2% | |
| Q3 2022 | -19.6% | -16.7% | -50.0% | |
| Q2 2022 | -6.5% | -4.2% | +23.9% | |
| Q1 2022 | +1.0% | +2.9% | -7.4% | |
| Q4 2021 | -1.2% | -6.1% | +2.0% | |
| Q3 2021 | -17.0% | -13.2% | -33.3% | |
| Q2 2021 | +9.6% | +7.9% | +3.0% | |
| Q1 2021 | -14.6% | -8.9% | +6.6% | |
| Q4 2020 | +5.7% | -6.2% | -21.3% | |
| Q3 2020 | -7.8% | -7.0% | +14.1% | |
| Q2 2020 | -16.0% | -32.0% | -68.0% | |
| Q1 2020 | -9.6% | -14.6% | +2.4% | |
| Q4 2019 | -28.8% | -33.9% | -29.0% | |
| Q3 2019 | -15.0% | -23.0% | -16.0% | |
| Q2 2019 | -1.2% | +2.0% | +0.4% | |
| Q1 2019 | -13.3% | -13.3% | -24.9% | |
| Q4 2018 | -12.6% | -25.6% | -69.8% | |
| Q3 2018 | +2.8% | +4.7% | -21.7% | |
| Q2 2018 | -26.4% | -37.4% | -23.9% | |
| Q1 2018 | -17.1% | -18.8% | -23.3% | |
| Q4 2017 | -15.5% | -25.7% | -21.0% | |
| Q3 2017 | -12.8% | -15.6% | -47.3% | |
| Q2 2017 | -4.0% | -13.3% | -6.7% | |
| Q1 2017 | -9.5% | -1.4% | -9.5% | |
| Q4 2016 | -5.3% | -12.0% | -58.0% | |
| Q3 2016 | -5.0% | -5.0% | +190.0% | |
| Q2 2016 | -14.9% | -16.0% | -17.0% | |
| Q1 2016 | +1.5% | — | — | |
| Q4 2015 | -15.9% | — | — | |
| Q3 2015 | -1.2% | — | — | |
| Q2 2015 | +0.7% | — | — | |
| Q1 2015 | -3.5% | — | — | |
| Q4 2014 | -0.2% | — | — | |
| Q3 2014 | -17.5% | — | — | |
| Q2 2014 | +23.9% | — | — | |
| Q1 2014 | +3.2% | — | — | |
| Q4 2013 | +2.1% | — | — | |
| Q1 2013 | +6.2% | — | — | |
| Q4 2012 | +2.6% | — | — | |
| Q2 2012 | -7.6% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro